| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265129 Anti-infective biaryl compounds |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265102 Substituted pyrazoles |
| 09/04/2007 | US7264891 Stability, efficiency and color purity |
| 09/04/2007 | CA2274063C Substituted pyrimidine compounds and their use |
| 09/04/2007 | CA2239174C Novel compounds with analgesic effect |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |
| 08/30/2007 | WO2007098386A1 Pyrazolylquinazolinones as potassium channel openers |
| 08/30/2007 | WO2007098270A2 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same |
| 08/30/2007 | WO2007098229A2 Geldanamycin derivatives and method of use thereof |
| 08/30/2007 | WO2007098214A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007098169A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096351A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders |
| 08/30/2007 | WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| 08/30/2007 | WO2007095812A1 Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof |
| 08/30/2007 | WO2007095789A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007064566A3 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 08/30/2007 | WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 08/30/2007 | WO2007034326A3 Imidazole compounds for the treatment of neurological disorders |
| 08/30/2007 | WO2007020533A3 Process for the preparation of losartan potassium |
| 08/30/2007 | WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/30/2007 | US20070203343 Cyanine Dye Labelling Reagents |
| 08/30/2007 | US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
| 08/30/2007 | US20070203340 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines |
| 08/30/2007 | US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 08/30/2007 | US20070203201 Substituted anthranilamides for controlling invertebrate pests |
| 08/30/2007 | US20070203197 Phosphodiesterase 4 inhibitors |
| 08/30/2007 | US20070203196 Methods of preparing indazole compounds |
| 08/30/2007 | US20070203195 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
| 08/30/2007 | US20070203186 N-(trans-4-tert-butylcyclohexyl)-1-{4-[(1h-tetrazol-5-ylamino)carbonyl]benzyl }-3-(3,4,5-trifluoropbenyl)-1h-pyrazole-5-carboxamide; type 2 diabetes, hyperglycemia, diabetes or insulin resistance, Syndrome X, atherosclerosis |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203162 Prevent transplant rejection; autoimmune diseases |
| 08/30/2007 | US20070203149 Ccr5 antagonists useful for treating hiv |
| 08/30/2007 | US20070203148 Haloalkyl Carboxamides |
| 08/30/2007 | US20070203134 Benzimidazole Acetonitriles |
| 08/30/2007 | US20070203130 sodium channel and calcium channel inhibitors, such as 2-Indol-1-yl-N-[5-(thiazol-2-ylsulfamoyl)-naphthalen-1-yl]-propionamide, used as analgesics or for the treatment of neurodegenerative disorders, anxiety, depression, arrhythmia, ataxia, multiple sclerosis, irritable bowel syndrome or incontinence |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070203128 Modulation of Pathogenicity |
| 08/30/2007 | US20070203124 Therapeutic Piperazines |
| 08/30/2007 | US20070203122 Derivatives for modulation of ion channels |
| 08/30/2007 | US20070203121 Substituted indole compounds, their preparation and use in medicaments |
| 08/30/2007 | US20070203120 Sulfonyl Substituted 1H-Indoles as Ligands for the 5-Hydroxytryptamine Receptors |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
| 08/30/2007 | US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 08/30/2007 | US20070200490 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same |
| 08/30/2007 | DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 08/30/2007 | CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | CA2643688A1 Co-crystals and pharmaceutical compositions comprising the same |
| 08/30/2007 | CA2642832A1 Pyrazolylquinazolinones as potassium channel openers |
| 08/30/2007 | CA2642762A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/30/2007 | CA2642229A1 Compositions and methods for inhibition of the jak pathway |
| 08/30/2007 | CA2638095A1 New compounds |
| 08/30/2007 | CA2637531A1 Compounds having 5-ht6 receptor affinity |
| 08/29/2007 | EP1824846A2 Novel compounds for the treatment of neurological disorders |
| 08/29/2007 | EP1824844A1 Pyrazine dicarboxamides and the use thereof |
| 08/29/2007 | EP1824843A2 Inhibitors of protein kinases |
| 08/29/2007 | EP1824839A2 Substituted biaryl analogues |
| 08/29/2007 | EP1824832A1 Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
| 08/29/2007 | EP1824338A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | EP1682533A4 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt |
| 08/29/2007 | EP1590344A4 Anti-cancer medicaments |
| 08/29/2007 | EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027290A Novel 2,3-phthalazinone derivatives, as AURORA-A kinase inhibitors |
| 08/29/2007 | CN101027286A Indozolone derivatives as 11b-HSD1 inhibitors |
| 08/29/2007 | CN101027060A Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024643A Imidazo-5-carboxylic-acid derivatives, its preparing method and use |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN100334084C Bi-triazole compound, preparation method and application thereof |
| 08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke |
| 08/28/2007 | US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts |
| 08/28/2007 | US7262202 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe. |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262200 Indazolinone compositions useful as kinase inhibitors |
| 08/28/2007 | US7262194 Therapeutic agents useful for treating pain |
| 08/28/2007 | US7261743 Dicationic compounds for dyeing human keratin fibers, and compositions comprising them |
| 08/28/2007 | CA2265874C Condensed n-acylindoles as antitumor agents |
| 08/23/2007 | WO2007095513A1 Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators |